Latest Breaking News On - Placebo controlled phase - Page 1 : comparemela.com

Oral PCSK9 inhibitor Significantly Reduces LDL-C in Hypercholesterolemia

Oral PCSK9 inhibitor Significantly Reduces LDL-C in Hypercholesterolemia
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

France
Linkedin-sharon-barr
Sharon-barr
European-atherosclerosis-society-congress
Astrazeneca
Front-public-health
First-oral-small-molecule
Placebo-controlled-phase
Global-burden
Lipid-lowering-therapies-over

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Spain
Ying-qian
Jiangxi
China
Madrid
Tianjin
Texas
United-states
Shanghai
Wuhan
Hubei
Norway

Dr Paul Frohna Discusses Promising Results of Novel Hedgehog Inhibitor for IPF

Promising results from a phase 2 trial of ENV-101, a novel hedgehog inhibitor, showed improvement in lung function and reduction of fibrosis in patients with idiopathic pulmonary fibrosis, said Paul Frohna, MD, PhD, PharmD.

California
United-states
San-diego
American
Paul-frohna
American-thoracic-society
International-conference
Endeavor-biomedicines
Novel-hedgehog-inhibitor
Increases-lung-function
Reduces-lung-fibrosis
Results-from

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 HUTCHMED Limited today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new.

Beijing
China
Spain
Tianjin
Shanghai
Oslo
Norway
Wuhan
Hubei
Ying-qian
Jiangxi
Valencia

HUTCHMED Data to be Presented at EHA2024 Congress | Company Announcement

Investegate announcements from HUTCHMED Data to be Presented at EHA2024 Congress

Spain
Cheng-mei
Guangdong
China
Oslo
Norway
Hong-kong
Tianjin
Houston
Texas
United-states
Beijing